1 Han B,Zheng R,Zeng H,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53. 2 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. 3 Kocarnik JM,Compton K,Dean FE,et al.Cancer incidence,mortality,years of life lost,years lived with disability,and disability-adjusted life years for 29 cancer groups from 2010 to 2019:a systematic analysis for the Global Burden of Disease Study 2019[J].JAMA Oncol,2022,8(3):420-444. 4 Wang H,Qin D,Fang L,et al.Addressing healthy aging in China:Practices and prospects[J].Biosci Trends,2024,18(3):212-218. 5 Li R,Cheng X,Schwebel DC,et al.Disability-adjusted life years associated with population ageing in China,1990-2017[J].BMC Geriatr,2021,21(1):369. 6 Chang AY,Skirbekk VF,Tyrovolas S,et al.Measuring population ageing:an analysis of the Global Burden of Disease Study 2017[J].Lancet Public Health,2019,4(3):e159-e167. 7 Valery PC,Laversanne M,Clark PJ,et al.Projections of primary liver cancer to 2030 in 30 countries worldwide[J].Hepatology,2018,67(2):600-611. 8 Moller B,Fekjaer H,Hakulinen T,et al.Prediction of cancer incidence in the Nordic countries:empirical comparison of different approaches[J].Stat Med,2003,22(17):2751-2766. 9 赵倩雯,佘欣,耿利军,等.1990—2021年中国胃癌发病趋势的年龄-时期-队列模型及预测[J].实用肿瘤学杂志,2024,38(5):289-294. 10 Cheng X,Yang Y,Schwebel DC,et al.Population ageing and mortality during 1990-2017:a global decomposition analysis[J].PLoS Med,2020,17(6):e1003138. 11 Zhang J,Pan L,Guo Q,et al.The impact of global,regional,and national population ageing on disability-adjusted life years and deaths associated with diabetes during 1990-2019:a global decomposition analysis[J].Diabetes Metab Syndr,2023,17(6):102791. 12 吴君,张文豪,徐阳.读懂人均预期寿命延长背后的民生福祉[N].人民日报,2025-03-13(14). 13 郑文龙,张爽,辛鹏,等.期望寿命变化趋势及其影响因素研究进展[J].中国慢性病预防与控制,2020,28(7):552-554. 14 Zhu J,Li S,Li X,et al.Impact of population ageing on cancer-related disability-adjusted life years:a global decomposition analysis[J].J Glob Health,2024,14:4144. 15 Xiang X,Chen X,He Y,et al.Pancreatic cancer challenge in 52 Asian countries:age-centric insights and the role of modifiable risk factors(1990-2019)[J].Front Oncol,2023,13:1271370. 16 Zhan C,Qiu B,Wang J,et al.Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021:findings from the global burden of disease study 2021[J].Front Oncol,2024,14:1499384. 17 李贺,高梓茗,李凯.基于GBD数据分析2000—2021年中国人群胃癌所致伤残调整寿命年负担趋势[J].中国肿瘤,2024,33(11):915-921. 18 Li M,Hu M,Jiang L,et al.Trends in cancer incidence and potential associated factors in China[J].JAMA Netw Open,2024,7(10):e2440381. 19 李全美,郑西特,黄凤仪,等.1990-2019年中国消化系统恶性肿瘤发病与死亡趋势分析和预测[J].中华肿瘤防治杂志,2025,32(5):259-266. 20 武春龙,孙伟玲.中国消化道肿瘤发病与死亡的年龄-时期-队列模型分析[J].实用肿瘤学杂志,2023(6):37. 21 Montegut L,Lopez-Otin C,Kroemer G.Aging and cancer[J].Mol Cancer,2024,23(1):106. 22 Ju W,Zheng R,Zhang S,et al.Cancer statistics in Chinese older people,2022:current burden,time trends,and comparisons with the US,Japan,and the Republic of Korea[J].Sci China Life Sci,2023,66(5):1079-1091. 23 Luo Y,Guo C,Wang Y,et al.Trends and challenges for population health and migration -China,2015-2050[J].China CDC Wkly,2020,2(28):520-524. 24 Lobanov-Rostovsky S,He Q,Chen Y,et al.Growing old in China in socioeconomic and epidemiological context:systematic review of social care policy for older people[J].BMC Public Health,2023,23(1):1272. 25 Scott AJ.The longevity society[J].Lancet Healthy Longev,2021,2(12):e820-e827. 26 於坛春,林琳,刘韫宁,等.基于GBD数据分析1990和2019年中国不同年龄人群恶性肿瘤死亡和伤残调整寿命年差异[J].中国肿瘤,2024,33(1):44-52. 27 Huang J,Lucero-Prisno D R,Zhang L,et al.Updated epidemiology of gastrointestinal cancers in East Asia[J].Nat Rev Gastroenterol Hepatol,2023,20(5):271-287. 28 He S,Xia C,Li H,et al.Cancer profiles in China and comparisons with the USA:a comprehensive analysis in the incidence,mortality,survival,staging,and attribution to risk factors[J].Sci China Life Sci,2024,67(1):122-131. 29 Chen S,Han K,Song Y,et al.Current status,trends,and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019[J].Chin Med J(Engl),2022,135(14):1697-1706. 30 Xie D,Liu F,Zhou D,et al.Global burden and cross-country inequalities in gallbladder and biliary tract cancer(1990-2021)with projections to 2050:insights from the global burden of disease study 2021[J].Front Med(Lausanne),2025,12:1520714. 31 Ladabaum U,Dominitz JA,Kahi C,et al.Strategies for colorectal cancer screening[J].Gastroenterology,2020,158(2):418-432. 32 Xia C,Basu P,Kramer BS,et al.Cancer screening in China:a steep road from evidence to implementation[J].Lancet Public Health,2023,8(12):e996-e1005. 33 Stoffel EM,Brand RE,Goggins M.Pancreatic cancer:changing epidemiology and new approaches to risk assessment,early detection,and prevention[J].Gastroenterology,2023,164(5):752-765. |